From Thresholds to Tumor Sidedness: Reframing Human Epidermal Growth Factor Receptor 2 in Colore

20 Jan 20264 min read0 viewsJournal Feed

GIST

Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 20 Jan 2026. The item focuses on Reply to: From Thresholds to Tumor Sidedness: Reframing Human Epidermal Growth Factor Receptor 2 in Colorectal Cancer. Review the original article for the full source wording and details.

Clinical Editorial

Summary

Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 20 Jan 2026.

The item focuses on Reply to: From Thresholds to Tumor Sidedness: Reframing Human Epidermal Growth Factor Receptor 2 in Colorectal Cancer.

Review the original article for the full source wording and details.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Oncology • 19 Mar 2026

Allan Trial: Impact of Early Home-Based Palliative Care on Emergency Care in Advanced GI Cancer

Oncology • 24 Apr 2026

Young-Onset Colorectal Cancer by Education

Oncology • 16 Apr 2026

Feed Metadata

Source

Journal of Clinical Oncology (JCO)